Business Context and Reporting Period
Company: Microbot Medical Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 27, 2025
Reporting Period: The filing addresses events occurring between December 26, 2024, and January 17, 2025, specifically regarding stock price compliance.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on regulatory compliance status regarding the company's stock listing.
Material Changes
Regulatory Status Change: The Company received notification from Nasdaq Stock Market LLC confirming it has regained compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)).
Stock Price Performance: The minimum closing bid price of the Company's common stock was at or above $1.00 per share for 15 consecutive business days from December 26, 2024, to January 17, 2025.
Outcome: The prior bid price deficiency matter is now considered closed by Nasdaq.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the resolution of the listing deficiency without providing forward-looking guidance, strategic outlook, or discussion of new risks.
Unusual Items: None reported in this filing.
Risks: The filing implies the removal of the immediate risk of delisting due to low bid price, as the deficiency has been resolved.
Investor Verification Checklist
- Verify the current trading price of Microbot Medical Inc. (MBOT) on the NASDAQ Capital Market to ensure continued compliance with the $1.00 minimum bid price.
- Review the Company's most recent 10-K or 10-Q filings for actual financial performance metrics, as this 8-K contains no financial data.
- Confirm that no other Nasdaq listing deficiencies exist beyond the resolved bid price issue.